MEDICLIN AG (MED.DE) Fundamental Analysis & Valuation

FRA:MED • DE0006595101

Current stock price

3.5 EUR
-0.04 (-1.13%)
Last:

This MED.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MED.DE Profitability Analysis

1.1 Basic Checks

  • In the past year MED was profitable.
  • MED had a positive operating cash flow in the past year.
  • Of the past 5 years MED 4 years were profitable.
  • Each year in the past 5 years MED had a positive operating cash flow.
MED.DE Yearly Net Income VS EBIT VS OCF VS FCFMED.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M 100M

1.2 Ratios

  • MED has a Return On Assets (3.03%) which is in line with its industry peers.
  • MED has a Return On Equity (10.24%) which is comparable to the rest of the industry.
  • With a decent Return On Invested Capital value of 6.23%, MED is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MED is in line with the industry average of 6.69%.
  • The 3 year average ROIC (5.02%) for MED is below the current ROIC(6.23%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.03%
ROE 10.24%
ROIC 6.23%
ROA(3y)1.52%
ROA(5y)1.15%
ROE(3y)5.3%
ROE(5y)4.24%
ROIC(3y)5.02%
ROIC(5y)3.67%
MED.DE Yearly ROA, ROE, ROICMED.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

  • MED has a better Profit Margin (3.17%) than 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of MED has grown nicely.
  • With a Operating Margin value of 6.88%, MED perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of MED has grown nicely.
  • MED has a Gross Margin of 84.41%. This is in the better half of the industry: MED outperforms 76.67% of its industry peers.
  • In the last couple of years the Gross Margin of MED has remained more or less at the same level.
Industry RankSector Rank
OM 6.88%
PM (TTM) 3.17%
GM 84.41%
OM growth 3Y41.41%
OM growth 5Y220.89%
PM growth 3Y34.34%
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y0.29%
MED.DE Yearly Profit, Operating, Gross MarginsMED.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MED.DE Health Analysis

2.1 Basic Checks

  • MED has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • MED has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MED has about the same amount of shares outstanding.
  • The debt/assets ratio for MED has been reduced compared to a year ago.
MED.DE Yearly Shares OutstandingMED.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
MED.DE Yearly Total Debt VS Total AssetsMED.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • MED has an Altman-Z score of 1.63. This is a bad value and indicates that MED is not financially healthy and even has some risk of bankruptcy.
  • MED's Altman-Z score of 1.63 is in line compared to the rest of the industry. MED outperforms 53.33% of its industry peers.
  • MED has a debt to FCF ratio of 7.66. This is a slightly negative value and a sign of low solvency as MED would need 7.66 years to pay back of all of its debts.
  • MED has a Debt to FCF ratio of 7.66. This is in the better half of the industry: MED outperforms 63.33% of its industry peers.
  • A Debt/Equity ratio of 1.46 is on the high side and indicates that MED has dependencies on debt financing.
  • MED has a Debt to Equity ratio of 1.46. This is comparable to the rest of the industry: MED outperforms 46.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF 7.66
Altman-Z 1.63
ROIC/WACC1.22
WACC5.1%
MED.DE Yearly LT Debt VS Equity VS FCFMED.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • MED has a Current Ratio of 1.68. This is a normal value and indicates that MED is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MED (1.68) is better than 80.00% of its industry peers.
  • A Quick Ratio of 1.65 indicates that MED should not have too much problems paying its short term obligations.
  • With an excellent Quick ratio value of 1.65, MED belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1.65
MED.DE Yearly Current Assets VS Current LiabilitesMED.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MED.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.64% over the past year.
  • The Earnings Per Share has been growing by 39.23% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 5.13% in the past year.
  • The Revenue has been growing slightly by 3.69% on average over the past years.
EPS 1Y (TTM)2.64%
EPS 3Y39.23%
EPS 5YN/A
EPS Q2Q%-96.23%
Revenue 1Y (TTM)5.13%
Revenue growth 3Y3.65%
Revenue growth 5Y3.69%
Sales Q2Q%3.65%

3.2 Future

  • MED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.36% yearly.
  • MED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.23% yearly.
EPS Next Y1.37%
EPS Next 2Y1.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.46%
Revenue Next 2Y2.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MED.DE Yearly Revenue VS EstimatesMED.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MED.DE Yearly EPS VS EstimatesMED.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

8

4. MED.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 6.48, the valuation of MED can be described as very cheap.
  • Based on the Price/Earnings ratio, MED is valued cheaper than 96.67% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of MED to the average of the S&P500 Index (27.18), we can say MED is valued rather cheaply.
  • The Price/Forward Earnings ratio is 4.68, which indicates a rather cheap valuation of MED.
  • 100.00% of the companies in the same industry are more expensive than MED, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of MED to the average of the S&P500 Index (37.96), we can say MED is valued rather cheaply.
Industry RankSector Rank
PE 6.48
Fwd PE 4.68
MED.DE Price Earnings VS Forward Price EarningsMED.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • MED's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MED is cheaper than 96.67% of the companies in the same industry.
  • 90.00% of the companies in the same industry are more expensive than MED, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.26
EV/EBITDA 2.91
MED.DE Per share dataMED.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.73
PEG (5Y)N/A
EPS Next 2Y1.36%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. MED.DE Dividend Analysis

5.1 Amount

  • MED has a Yearly Dividend Yield of 1.16%.
  • MED's Dividend Yield is comparable with the industry average which is at 1.83.
  • Compared to the average S&P500 Dividend Yield of 1.82, MED is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.16%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MED.DE Yearly Dividends per shareMED.DE Yearly Dividends per shareYearly Dividends per share 2019 2025 2026 0.01 0.02 0.03 0.04

5.3 Sustainability

  • 7.45% of the earnings are spent on dividend by MED. This is a low number and sustainable payout ratio.
DP7.45%
EPS Next 2Y1.36%
EPS Next 3YN/A
MED.DE Yearly Income VS Free CF VS DividendMED.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M
MED.DE Dividend Payout.MED.DE Dividend Payout, showing the Payout Ratio.MED.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MED.DE Fundamentals: All Metrics, Ratios and Statistics

MEDICLIN AG

FRA:MED (4/13/2026, 7:00:00 PM)

3.5

-0.04 (-1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-26
Earnings (Next)05-04
Inst Owners0.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap166.25M
Revenue(TTM)804.32M
Net Income(TTM)25.49M
Analysts80
Price Target5.87 (67.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.16%
Yearly Dividend0.04
Dividend Growth(5Y)N/A
DP7.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)9.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.45%
Valuation
Industry RankSector Rank
PE 6.48
Fwd PE 4.68
P/S 0.21
P/FCF 3.26
P/OCF 1.62
P/B 0.67
P/tB 0.72
EV/EBITDA 2.91
EPS(TTM)0.54
EY15.43%
EPS(NY)0.75
Fwd EY21.35%
FCF(TTM)1.07
FCFY30.69%
OCF(TTM)2.16
OCFY61.62%
SpS16.93
BVpS5.24
TBVpS4.88
PEG (NY)4.73
PEG (5Y)N/A
Graham Number7.98
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 10.24%
ROCE 8.24%
ROIC 6.23%
ROICexc 7.98%
ROICexgc 8.25%
OM 6.88%
PM (TTM) 3.17%
GM 84.41%
FCFM 6.34%
ROA(3y)1.52%
ROA(5y)1.15%
ROE(3y)5.3%
ROE(5y)4.24%
ROIC(3y)5.02%
ROIC(5y)3.67%
ROICexc(3y)6.5%
ROICexc(5y)4.72%
ROICexgc(3y)6.76%
ROICexgc(5y)4.97%
ROCE(3y)6.64%
ROCE(5y)4.85%
ROICexgc growth 3Y50.89%
ROICexgc growth 5Y238.46%
ROICexc growth 3Y54.07%
ROICexc growth 5Y243.02%
OM growth 3Y41.41%
OM growth 5Y220.89%
PM growth 3Y34.34%
PM growth 5YN/A
GM growth 3Y1.13%
GM growth 5Y0.29%
F-Score7
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.46
Debt/FCF 7.66
Debt/EBITDA 3.13
Cap/Depr 85.39%
Cap/Sales 6.39%
Interest Coverage 2.64
Cash Conversion 88.63%
Profit Quality 200.16%
Current Ratio 1.68
Quick Ratio 1.65
Altman-Z 1.63
F-Score7
WACC5.1%
ROIC/WACC1.22
Cap/Depr(3y)72.65%
Cap/Depr(5y)55.5%
Cap/Sales(3y)5.71%
Cap/Sales(5y)4.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3Y39.23%
EPS 5YN/A
EPS Q2Q%-96.23%
EPS Next Y1.37%
EPS Next 2Y1.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.13%
Revenue growth 3Y3.65%
Revenue growth 5Y3.69%
Sales Q2Q%3.65%
Revenue Next Year2.46%
Revenue Next 2Y2.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.51%
EBIT growth 3Y46.57%
EBIT growth 5Y232.74%
EBIT Next Year84.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.2%
FCF growth 3Y80.88%
FCF growth 5Y-11.22%
OCF growth 1Y27.15%
OCF growth 3Y43.54%
OCF growth 5Y-2.84%

MEDICLIN AG / MED.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MEDICLIN AG (MED.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MED.DE.


Can you provide the valuation status for MEDICLIN AG?

ChartMill assigns a valuation rating of 8 / 10 to MEDICLIN AG (MED.DE). This can be considered as Undervalued.


How profitable is MEDICLIN AG (MED.DE) stock?

MEDICLIN AG (MED.DE) has a profitability rating of 6 / 10.


What is the earnings growth outlook for MEDICLIN AG?

The Earnings per Share (EPS) of MEDICLIN AG (MED.DE) is expected to grow by 1.37% in the next year.


Is the dividend of MEDICLIN AG sustainable?

The dividend rating of MEDICLIN AG (MED.DE) is 3 / 10 and the dividend payout ratio is 7.45%.